Filter
715
Text search:
good
manufacturing
practices
Featured
57
194
Language
Document type
368
137
108
43
33
9
8
6
1
1
1
Countries / Regions
34
33
25
20
19
18
18
16
15
13
13
12
12
10
10
10
9
8
7
7
7
7
7
7
6
6
5
5
5
4
4
4
4
4
4
4
4
4
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
279
39
37
34
27
18
7
Toolboxes
69
62
55
42
40
22
19
19
16
14
13
13
11
11
10
8
8
7
5
4
3
2
The manufacturing process is one of the key steps where quality control is required to ensure quality of medicinal products, including herbal medicines. Good
...
The main objectives of these guidelines are to:
1. contribute to the quality assurance of medicinal plant materials used as the source for herbal medicines to improve the quality, safety and efficacy of finished herbal products; 2. guide the formulation of national and/or regional GACP guideli ...
1. contribute to the quality assurance of medicinal plant materials used as the source for herbal medicines to improve the quality, safety and efficacy of finished herbal products; 2. guide the formulation of national and/or regional GACP guideli ...
The African Centers for Disease Control and Prevention and the African Union together have called for a New Public Health Order which will safeguard the health and economic security of the continent as it strives to meet the aspirations of the Agenda 2063. A key pillar of this mandate seeks to expan
...
Licensed pharmaceutical products (marketing authorization) should be manufactured only by licensed manufacturers (holders of a manufacturing authorization) whose activities are regularly inspected by competent national authorities. This guide to GMP
...
Good Manufacturing Practice (GMP) describes a set of principles and procedures that, when followed, ensure that medicines and related substances are of high quality, safety and efficacy. SAHPRA is a
...
Drug Advisory Board
A view of global supply chains, pressure points, and implications for antimicrobial resistance response
Environmental pollution, protection, quality and sustainability
In preparing this paper, the Pharmacovigilance Group of the Pan American Health Organization’s Pan American Network for Drug Regulatory Harmonization (PANDRH) adopted the perspective of PAHO/WHO, which considers Pharmacovigilance, an essential component of public health programs. Its intention was
...
Minimizing risk of developing antibiotic resistance and aquatic ecotoxicity in the environment resulting from the manufacturing of human antibiotic.
The Standard, facilitated by BSI Standards Limited (BSI), provides clear guidance to manufacturer
...
The Virtual cGMP Training Marathon for Vaccine Manufacturing: Principles into Practice took place from 12 Sep to 10 Oct 2023 to continue to provide manufacturers & regulators with a comprehensive array of topics to build understanding of current WHO
...
Doc. No.: INS/GDL/001-(Annexes)
Compilation of country case studies and best practices. World Health Report (2010) Background Paper, 25
